sarpogrelate has been researched along with Coronary Occlusion in 1 studies
sarpogrelate: structure given in first source
Coronary Occlusion: Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barta, J | 1 |
| Sanganalmath, SK | 1 |
| Kumamoto, H | 1 |
| Takeda, N | 1 |
| Edes, I | 1 |
| Dhalla, NS | 1 |
1 other study available for sarpogrelate and Coronary Occlusion
| Article | Year |
|---|---|
Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cilostazol; Coronary Occlusion; Cyclic AMP; D | 2008 |